Navigation Links
Aratana Therapeutics to Host Pet Therapeutics Primer and Product Update Event
Date:8/29/2013

#160;

Dr. Ernst Heinen, Aratana's Head of Drug Development and Evaluation, will provide an in-depth development update for each of Aratana's current product candidates, each of which is being developed concurrently for both cats and dogs.  These include AT-001, the Company's EP4 antagonist for the treatment of pain; AT-002, its ghrelin agonist for treating inappetence; and AT-003, Aratana's liposomal bupivacaine injection for treating post-operative pain.

There will be an opportunity for Q&A after each session, during which Dr. Marie-Paul Lachaud, Aratana's Head of Drug Development in Europe; Tammy Newbold, Aratana's Vice President of Chemistry, Manufacturing and Controls; and Don Stitzenberg, Aratana's Vice President of Manufacturing, will also be available.

About Aratana Therapeutics
Aratana Therapeutics is a development-stage biopharmaceutical company focused on the licensing, development and commercialization of innovative medications for pets, or pet therapeutics. Aratana believes that it can leverage the investment in the human biopharmaceutical industry to bring therapeutics to pets in a capital and time efficient manner. Aratana's strategy is to in-license proprietary compounds from human biopharmaceutical companies and to develop these product candidates into therapeutics specifically for use in pets. Aratana believes the development and commercialization of these therapeutics will permit veterinarians and pet owners to manage pets' medical needs safely and effectively, resulting in longer and improved quality of life for pets.  For more information, please visit www.aratana.com.

Contacts:
Tiberend Strategic Advisors, Inc.

Joshua Drumm, Ph.D. (investors)

SOURCE Aratana Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Aratana Therapeutics Reports Second Quarter 2013 Financial Results
2. Aratana Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering
3. Aratana Therapeutics to Present at Two Upcoming Healthcare Conferences
4. Aratana Closes $12 Million Series C Financing to Fund Pipeline Expansion
5. Aratana Therapeutics Appoints Erick Lucera Vice President of Corporate Development
6. Aratana to Present at Bank of America Merrill Lynch Animal Health Summit
7. Aratana to Participate in Leerink Swanns November Management Access Days
8. Carolus Therapeutics and The Alpha-1 Project Collaborate to Validate CT-2009 Target as Important in Human Disease
9. Echo Therapeutics Announces Management Changes
10. aTyr Pharma Awarded Two Patents from USPTO to Support Development of New Therapeutics Based on Physiocrine Biology
11. aTyr Pharma Expands Executive Leadership Team to Support Development of New Therapeutics Based on Physiocrine Biology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)...  Strategic Health Services, Inc. (SHS), a leading provider ... strategic agreement with QualCare, Inc., a leading provider of health ... regional marketplace.  This agreement will further QualCare,s population health ... QualCare brings to its clients in New ... QualCare plans cover more than 800,000 member lives, ...
(Date:12/17/2014)... 17, 2014  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE ... Trademark Office (USPTO) has issued a key patent ... immunotherapeutic vaccine targeting six tumor antigens that are ... Patent No. 8,871,211, which issued October 28, 2014, ... a dendritic cell composition comprising peptide epitopes of ...
(Date:12/15/2014)... 15, 2014 Registreer nu via  ... und 20. Februar sind alle akkreditierten pharmazeutischen ... ECOSYSTEM PARTNER PROGRAMM ™ 2015 in ... Diese Tagung soll dazu beitragen, der ... die neue profitablen Unternehmensdienstleistungen, die für Apotheken ...
Breaking Medicine Technology:Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2
(Date:12/17/2014)... 2014 (HealthDay News) -- Greater participation in music classes ... Researchers followed kids in the nonprofit Harmony Project, ... in Los Angeles. Over two years, children who ... how the brain processes speech and reading, compared to ... benefits of active participation in music classes occurred in ...
(Date:12/17/2014)... Doheny HealthDay Reporter , TUESDAY, ... rampant in America, and work commitment is a big reason ... sleep killer," said Dr. Mathias Basner, an assistant professor of ... Perelman School of Medicine. A time-use survey of nearly ... is the main activity exchanged for sleep. Short sleepers -- ...
(Date:12/15/2014)... Veretekk.com, Inc. announced today a strategic ... JM Ocean Avenue has secured exclusive benefit to the ... system. JM Ocean Avenue is a direct sales ... Avenue and JM International, with partial ownership coming from ... company. , “After nearly 2 decades of servicing the ...
(Date:12/15/2014)... a leading mobile app development company , custom ... which allows users to keep track of wines they ... right wine. At the center of WineMatch is ... wine information. All this information is assembled to help ... are close counterparts to one another are called Matches. ...
(Date:12/15/2014)... Steven Reinberg HealthDay Reporter ... study should reassure the millions of American women who have ... cancer. "There is no association between migraine and breast ... of medicine at Harvard Medical School. "There is no positive ... is no protective effect either." About 18 percent of ...
Breaking Medicine News(10 mins):Health News:Music Classes Boost Language Skills, Study Says 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2Health News: No Link Between Migraine, Breast Cancer Risk, Study Says 2
... of anti-malarial drugs have made thousands of people’s life ... laws and provisions// against counterfeiters aroused – said experts. ... PLoS Medicine issue that due to counterfeiters malarial parasites ... condition. ,Facundo Fernandez, a co-author of the ...
... - Patients with an implantable cardioverter defibrillator did not ... rhythms// or death by consuming fish oil supplements, which ... to a study in the June 14 issue of ... approximately 50 percent of all death from cardiovascular disease ...
... Surgery According to the National Prostate Cancer Coalition's (NPCC) ... surgery still remains// the most common treatment choice of ... external beam radiation. ,60% of men who ... while 41% reported that they had hormone treatment with ...
... now become fond of tasting vegetables or desserts items rather ... about 200 pairs of same-sex twins. ,‘Heritability Factor’, ... beef, lamb, fish, bacon and chicken. But by contrast, environmental ... preferably. ,Mothers of 103 pairs of identical twins ...
... during pregnancy may lead to various health complications in ... anti-oxidant found naturally in foods like nuts, vegetable oil ... particularly taken with vitamin C, could help protect against ... who led a two-year study at St. Thomas' Hospital ...
... diabetes, one of the world’s leading debilitating diseases, has reached ... adults worldwide. Therefore, there is a huge demand for innovative ... ,There are two types of diabetes: ... 5% of all the cases. This type is the direct ...
Cached Medicine News:Health News:Fish Oil does not Appear to Protect Against Abnormal Heart Rhythms 2Health News:Inhaled Insulin: A New Modality for Management of Diabetes 2
... ideal system for fast, accurate filling of 96 ... valve controlled dispensing mechanism, ensures that no liquid ... components that come into contact with the liquid ... The unique compact design saves valuable bench space ...
... The QFill2 is the ideal system for fast, ... The pressure driven, pinch valve controlled dispensing mechanism, ... Whilst all of the components that come into ... dismantle, clean, and autoclave. The unique compact design ...
... low volumes. Dispenses volumes down to 0.5ul ... throughput of less than 30 seconds per ... an intuitive user interface that provides one-button ... liquids and suspensions, beads, or cells, with ...
... The Apricot Personal Pipettor is ... simple automated pipetting needs, from ... transfers and more. Systems are ... shuttle-based models, using either fixed ...
Medicine Products: